AMAG - AMAG Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue474,002495,769432,487418,276
Cost of Revenue243,790217,302146,492117,399
Gross Profit230,212278,467285,995300,877
Operating Expenses
Research Development16,94819,06415,38313,980
Selling General and Administrative277,417225,837143,785156,038
Non Recurring----
Others----
Total Operating Expenses538,155462,203305,660287,417
Operating Income or Loss-64,15333,566126,827130,859
Income from Continuing Operations
Total Other Income/Expenses Net-65,532-413,973-111,563-91,015
Earnings Before Interest and Taxes-64,15333,566126,827130,859
Interest Expense-51,971-68,382-73,153-53,251
Income Before Tax-129,685-380,40715,26439,844
Income Tax Expense39,654-175,25413,1717,065
Minority Interest----
Net Income From Continuing Ops-169,339-205,1532,09332,779
Non-recurring Events
Discontinued Operations103,5785,925-4,576-4,576
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-65,761-199,228-2,48332,779
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-65,761-199,228-2,48332,779